EpigenDx Revenue and Competitors

EpigenDx was incorporated in 2006 as a genomic and epigenomic research company specializing in disease biomarker discovery, validation and molecular diagnosis, with an unmatched expertise in the field of DNA methylation analysis. EpigenDx provides superior products and laboratory services for scientific researchers from academic, government and industrial communities from all over the world. Our commitment to quality reflects our desire and dedication to provide the best products and services to our customers. EpigenDx has extensive knowledge and expertise in Pyrosequencing, bisulfite sequencing, and various epigenomic research analysis techniques and methods stemming from our years of experience in the industry. EpigenDx Lab Services include: DNA Methylation - Bisulfite Pyrosequencing: determine loci specific methylation and global methylation levels individual CpGs sites - Targeted MethylSeq: determine methylation levels in multiple targeted regions at base pair resolution Expression Analysis - Gene and miRNA profiling using Affymetrix Gene Chip arrays Mutation & SNP Analysis - Quantative mutation analysis using Pyrosequencing for minor allele detection, allele specific expression - 1.8 million SNPs and copy number changes using Affymetrix 6.0 Array EpigenDx products include: DNA Methylation Controls: low and high methylated genomic DNA for studying human, mouse, rat genes Validated loci specific DNA methylation assays for multiple platforms including bisulfite sequencing, bisulfite Pyrosequencing, and realtime based PCR analysis. All assays are validated for PCR bias or preferential amplification. Methylation Panels including Stem Cell Panel, Cancer Panel, Immunology Panel, and CNS Panel. They are designed for bisulfite sequencing analysis using either Pyrosequencing or NGS platforms.